Xtant Medical Holdings, Inc. XTNT

About Xtant Medical Holdings, Inc. (XTNT): stock profile, AI score and financials

Xtant Medical Holdings, Inc. (XTNT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores XTNT at 24.6/100 on a composite quality score built from its SEC filings, placing it at rank #2,656 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (15.2) and revenue scale (17.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 37.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Xtant Medical Holdings, Inc. reports quarterly revenue of $23.0M, net income of $-9.4M, an operating margin of -39.8%. Top institutional holders of XTNT by reported 13-F value include Nantahala Capital Management, AWM Investment Company, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. XTNT trades on the NYSE exchange and files with the SEC under CIK 1453593. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate XTNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Xtant Medical Holdings, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1453593 →